Catecholamine Release–Inhibitory Peptide Catestatin (Chromogranin A 352–372 ) | Zendy

Fangwen Rao | Zendy; Gen Wen | Zendy; Jiaur R. Gayen | Zendy; Madhusudan Das | Zendy; Sucheta M. Vaingankar | Zendy; Brinda K. Rana | Zendy; Manjula Mahata | Zendy; Brian P. Kennedy | Zendy; Rany M. Salem | Zendy; Mats Stridsberg | Zendy; Kenneth J. Abel | Zendy; Douglas W. Smith | Zendy; Eleazar Eskin | Zendy; Nicholas J. Schork | Zendy; Bruce A. Hamilton | Zendy; Michael G. Ziegler | Zendy; Sushil K. Mahata | Zendy; Daniel T. O’Connor | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Catecholamine Release–Inhibitory Peptide Catestatin (Chromogranin A _352–372 )

Author(s) -

Fangwen Rao,

Gen Wen,

Jiaur R. Gayen,

Madhusudan Das,

Sucheta M. Vaingankar,

Brinda K. Rana,

Manjula Mahata,

Brian P. Kennedy,

Rany M. Salem,

Mats Stridsberg,

Kenneth J. Abel,

Douglas W. Smith,

Eleazar Eskin,

Nicholas J. Schork,

Bruce A. Hamilton,

Michael G. Ziegler,

Sushil K. Mahata,

Daniel T. O’Connor

Publication year - 2007

Publication title -

circulation

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.106.628859

Subject(s) - chromogranin a , catecholamine , medicine , inhibitory postsynaptic potential , endocrinology , pharmacology , immunohistochemistry

Chromogranin A, coreleased with catecholamines by exocytosis, is cleaved to the catecholamine release-inhibitory fragment catestatin. We identified a natural nonsynonymous variant of catestatin, Gly364Ser, that alters human autonomic function and blood pressure.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research